8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
People assigned to a diet, food or program and measured.
2019 / Open-label, randomized counterbalanced crossover trial
Seven healthy older overweight volunteers completed four trials consuming a >900 kcal meal with water (control), orange juice, green tea, or red wine, with at least 3 days between visits. At 2 hours post-meal, triglycerides increased substantially and flow-mediated dilatation (FMD) was significantly reduced by ~35%, accompanied by a reduction in plasma nitrite. Co-ingestion of the antioxidant drinks did not attenuate the reduction in FMD and none of the measured outcomes were influenced by the drinks.
Muggeridge DJ, Goszcz K, Treweeke A, et al. Front Physiol, 2019. PMID 31681007
2014 / Randomized controlled crossover trial
Twelve healthy, normotensive African-American females were evaluated at rest and during cycle ergometer exercise at 40%, 60%, and 80% of peak VO2 after receiving experimental beetroot juice or an isocaloric, isovolumetric placebo orange juice on separate days. Beetroot juice increased plasma nitric oxide concentration and decreased oxygen consumption, systolic blood pressure, and the heart rate-SBP product both at rest and across all three exercise intensities. No significant effects were observed on respiratory quotient, minute ventilation, heart rate, or diastolic blood pressure.
Bond V, Curry BH, Adams RG, et al. Appl Physiol Nutr Metab, 2014. PMID 24476472
2014 / Single-blind randomized crossover controlled trial
Twenty-two healthy volunteers participated in a randomized crossover trial comparing 4 weeks of commercial orange juice (COJ) and 4 weeks of fresh orange juice (FOJ). Consumption of both juices decreased VCAM, hs-CRP, and E-selectin, while increasing apo A-1 levels. Additionally, a decline in LDL was observed in the FOJ group, with the largest variations overall occurring in hs-CRP and VCAM in both groups.
Asgary S, Keshvari M, Afshani MR, et al. ISRN Nutr, 2014. PMID 24967267
2012 / Randomized controlled trial
Following a 3-week washout diet, 74 overweight adults were randomized to either a control diet (n=32) or one half of a fresh Rio-Red grapefruit with each meal (3x daily, n=42) for 6 weeks. No differences between groups were demonstrated for weight, blood pressure, or lipids. Within the grapefruit group, significant baseline-to-endpoint reductions occurred in waist circumference (-2.45 ± 0.60 cm, P = .0002), systolic blood pressure (-3.21 ± 10.13 mm Hg, P = .03), total cholesterol (-11.7 mg/dL, P = .002), and LDL (-18.7 mg/dL, P < .001), alongside non-significant weight loss (-0.61 ± 2.23 kg, P = .097).
Dow CA, Going SB, Chow HH, et al. Metabolism, 2012. PMID 22304836
2011 / Randomized crossover trial
In a randomized crossover study of 24 healthy, overweight men, daily consumption of 500 mL orange juice or a control drink with hesperidin for 4 weeks significantly reduced diastolic blood pressure compared to placebo (P=0.02). Fasting microvascular endothelium-related reactivity showed no significant change, but both orange juice and hesperidin significantly improved postprandial microvascular endothelial reactivity compared with placebo (P<0.05).
Morand C, Dubray C, Milenkovic D, et al. Am J Clin Nutr, 2011. PMID 21068346
2011 / Randomized trial
Eighty-five obese adults on a caloric restriction diet were randomly assigned to consume 127 g of grapefruit, grapefruit juice, or water as a preload before meals for 12 weeks. Overall, participants reduced average dietary energy density and total energy intakes by 20-29% and achieved a 7.1% weight loss alongside decreases in body fat and waist circumference (-4.5 cm), with no statistically significant differences among preload groups. However, changes in serum HDL cholesterol were significantly greater in the grapefruit (+6.2%) and grapefruit juice (+8.2%) groups compared to the water group (-3.7%).
Silver HJ, Dietrich MS, Niswender KD Nutr Metab (Lond), 2011. PMID 21288350
2011 / Placebo-controlled crossover trial
In a placebo-controlled crossover study with 16 male and female participants across 4 visits, subjects consumed a typical breakfast with placebo (sugar and ascorbic acid), placebo plus hesperidin, placebo plus a mixture of hesperidin, luteolin, and naringenin, or orange juice. Serum ORAC and lipoprotein oxidation lag time significantly increased in both the orange juice and placebo plus mixture groups. Total plasma phenolics data were inconsistent with ORAC and lipoprotein oxidation results, but findings indicate orange phenolic compounds contribute directly to postprandial oxidative protection.
Snyder SM, Reber JD, Freeman BL, et al. Nutr Res, 2011. PMID 21840468
2011 / Randomized crossover trial
In a randomized crossover study with 10 overnight-fasted volunteers analyzed, daily intake of 500 mL orange juice for 4 weeks altered the expression of 3,422 leukocyte genes, while hesperidin modulated 1,819 genes. The two treatments shared 1,582 commonly regulated genes. Many of the modulated genes were involved in cell chemotaxis, adhesion, infiltration, and lipid transport.
Milenkovic D, Deval C, Dubray C, et al. PLoS One, 2011. PMID 22110589
2010 / Clinical trial
In fasting healthy participants, 300-calorie drinks of glucose or cream increased NF-kappaB binding along with SOCS3, TNF-alpha, and IL-1beta expression in mononuclear cells over five hours. Only cream ingestion elevated circulating endotoxin concentrations and TLR-4 expression. In contrast, equicaloric amounts of orange juice or water prompted no alterations in any measured inflammatory or endotoxin markers.
Deopurkar R, Ghanim H, Friedman J, et al. Diabetes Care, 2010. PMID 20067961
2010 / Randomized controlled trial
A 3-month randomized trial evaluated 500 mL daily orange juice paired with aerobic training versus aerobic training alone in 26 overweight middle-aged women. The orange juice group experienced a 15% decrease in LDL cholesterol and an 18% increase in HDL cholesterol (both P < 0.05), whereas controls had no significant lipid changes. Blood lactate decreased more with orange juice (27% vs 17%), while both groups improved anaerobic threshold by 20%.
Aptekmann NP, Cesar TB Maturitas, 2010. PMID 20729016
2006 / Randomized controlled trial
Fifty-seven hyperlipidemic patients following coronary bypass surgery were randomly divided into three groups of 19: red grapefruit, blond grapefruit, or control for 30 consecutive days. Compared to the control group, patients receiving red and blond grapefruit showed reductions in total cholesterol (15.5% and 7.6%), LDL cholesterol (20.3% and 10.7%), and triglycerides (17.2% and 5.6%), respectively. No changes in serum lipid levels were observed in the control group. In vitro analyses also showed red grapefruit had higher contents of bioactive compounds and antioxidant potential than blond grapefruit.
Gorinstein S, Caspi A, Libman I, et al. J Agric Food Chem, 2006. PMID 16506849
2000 / Randomized crossover trial
In ten healthy adults consuming 5 to 7.5 mL/kg daily of juice for 7 to 10 days, purple grape juice lowered platelet clumping in response to 1 mg/L collagen by 77% (falling from 17.9 ± 2.3 to 4.0 ± 6.8 ohms, P = 0.0002). In contrast, orange juice and grapefruit juice exerted no effect on platelet activity. The grape juice contained roughly threefold the total polyphenols present in the citrus beverages.
Keevil JG, Osman HE, Reed JD, et al. J Nutr, 2000. PMID 10613766
2000 / Dose-escalation sequential trial
In an uncontrolled sequential trial, 25 adults with moderate hypercholesterolemia consumed 250, 500, and 750 mL of orange juice daily for 4 weeks each, followed by a 5-week washout. Intake of 750 mL daily increased HDL cholesterol by 21% (P < 0.001), triacylglycerols by 30% (P < 0.02), and folate by 18% (P < 0.01), while reducing the LDL-to-HDL ratio by 16% (P < 0.005). Daily doses of 250 or 500 mL had no significant effect on HDL cholesterol.
Kurowska EM, Spence JD, Jordan J, et al. Am J Clin Nutr, 2000. PMID 11063434